PRIMROSE THERAPEUTICS, INC.

Profile

Company Names

PRIMROSE THERAPEUTICS, INC.

Addresses

875 THIRD AVENUE, 3RD FLOOR, NEW YORK, NY 10022

Phone Numbers

212-632-5404

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$752,550.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2010-07-30 
$752,550.00 
$1,502,550.00 
$750,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY 
S. 
EDELMAN 
EXECUTIVE OFFICER, DIRECTOR
PRIMROSE THERAPEUTICS, INC.   |  SCA VALUE FUND, L.P.   |  SYMPHONY HEATHCARE VALUE FUND, L.P.   |  SYMPHONY HEALTHCARE VALUE FUND, L.P.   |  PAVADI HEALTHCARE VALUE LONG ONLY FUND LP   |  PAVADI HEALTHCARE VALUE FUND LP
MARK 
 
KESSEL 
EXECUTIVE OFFICER, DIRECTOR
RENAVANCE PHARMA, INC.   |  DYNAVAX TECHNOLOGIES CORP   |  OXIGENE INC   |  PRIMROSE THERAPEUTICS, INC.
ZACHARY 
S. 
SHARON 
EXECUTIVE OFFICER, DIRECTOR
PRIMROSE THERAPEUTICS, INC.   |  SCA VALUE FUND, L.P.   |  SYMPHONY HEATHCARE VALUE FUND, L.P.   |  SYMPHONY HEALTHCARE VALUE FUND, L.P.   |  PAVADI HEALTHCARE VALUE LONG ONLY FUND LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2010-08-13
D
Link
PHARMACEUTICALS 
 
NOT APPLICABLE 
Equity 
2010-07-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#